If you haven’t Googled yourself or your blog’s title in a while, you might just want to. It’s fun. I mean, I think all of us who are writing want exposure and want to develop a following, but you might be surprised to see what’s out there.
There has always been that ominous warning that once something is put out there on the Net, it’s out there forever. Like it or not. But that seems like a warning more appropriate for those crazy pictures people are inclined to put on their not-so-private Facebook pages. Beware future employers 🙂
All things and words can fade with time. Right?
You might want to rethink that before you put your next rant out there for the world to see.
When I was writing for newspapers and magazines in the 90’s, and then later blogging in the early 2000s, it seemed like my articles were perpetually floating around. Now, those have virtually disappeared. With a few interesting exceptions.
You see, other folks out there might snap up your writing up and use it for a purpose you never imagined. Or, in one instance, I even received an “award,” or recognition, I never knew about until years later.
In 1997, I authored a couple of editorials on vaccines. Mind you, I’m not against vaccines. All mine are up to date. But I do believe people should retain their choice on whether they wish to have foreign chemical substances injected into their bodies. Especially when toxic chemicals are added as preservatives. And especially when those substances may be contaminated with other substances that you might not want in your body. And especially since diseases can still be transmitted by those who are vaccinated.
I don’t believe in government coerced Kool-Aid.
At any rate, my articles might seem controversial. I didn’t really think so since there was plenty of research to back up the data, and I believed the articles to be balanced in their presentation. Nonetheless, they caused a bit of a stir when they were published. And guess what, after all these years, they’re still floating about on the Internet.
I had published these articles with the Albion Monitor, and they had a great website. Full attribution credit goes to them. Here is their obituary:
R.I.P. Albion Monitor, born August 19, 1995 and passed away at May 5, 2009, at the age of slightly over 5,000 days, having published 13,000 articles, giver take. The corpse will remain on view indefinitely at http://www.albionmonitor.com and is survived by a handful of good on-line news operations, scads of blogs, and ten million tweets.
But, and this is a big BUT, after my articles were published on the Monitor some other webpages used my stories for their own purposes. Purposes I would have never agreed to.
The first article was about contaminated polio vaccine. It turns out I tied in 12th place for Project Censored 1999 Top 25 Censored Stories with this one. You can find references to that here:
And here are a few websites where you can still find my article now:
The second article was about safety issues with the DPT vaccine. And here are a few websites where you can still find either my article or references to it:
http://crazzfiles.com/vaccine-damaged-child-medically-kidnapped-when-parents-refuse-toxic-chemicals-and-choose-organic-foods/ Note: They mistakenly called me a doctor in this one.
The point being, once my articles were out there, I had no editorial control. No one asked me for permission to use them or associate them with whatever their cause might be. And it would not be an easy thing to get those sites to take down my articles. Oh well.
I guess the message is write good content you’ll always be happy with no matter where it might show up 🙂
If any of you have had similar experiences, please feel free to share.
Photo: An image I took of a unique location becomes its negative, or you might say an altered view with repeated printings – just like our stories can become over time 🙂
Note: All web links are subject to link rot.
By-the-way, I’ve been playing “Whack-a-Mole today with WordPress on spacing issues with this piece. Each time I correct a spacing error, another is created, or a corrected line reverts back to an uncorrected state. Or it takes two line spaces to create one. Anybody else have these problems with WordPress?
And here are the articles and their references if anyone wants to read further.
The Forty Year Legacy of Tainted Polio Vaccine
In the late 1940’s and early 1950’s the polio virus was taking a savage toll on the American public. Thousands of children and adults were crippled or killed. In 1955, Jonas Salk performed a medical miracle when he discovered how to mass produce polio vaccine by growing it on the kidneys of rhesus monkeys. While there is no question that thousands were saved from the ravages of polio by the Salk vaccine, by 1960 a problem had surfaced — a problem which would come back to haunt the nation some forty years later.
The complication researchers had isolated in 1960 was a viral contaminate.
It seems that when the live polio virus grown on monkey tissues was extracted for vaccine production another virus was extracted as well, SV-40. When this monkey virus was injected into research animals it produced brain cancer. It appears our government didn’t wish to create a public panic or discredit the public health service, because instead of recalling the tainted vaccines, it quietly ordered the manufacturers to find a monkey free of SV-40 and continue production. As of 1963, the rhesus monkey had been replaced with the African green monkey for production of a safer polio vaccine, but between the years of 1955 and 1963 as many as 98 million Americans had received doses of live polio virus vaccines tainted with SV-40.
Jumping to the early 1990’s, Michele Carbone, Assistant Professor of Pathology at Loyola University in Chicago, isolated fragments of the SV-40 virus in human bone cancers and in a particularly nasty form of lung cancer called mesotheliomas. The viral contaminate from the 50s was back to haunt us, and appeared in 33% of the osteosarcoma bone cancers studied, in 40% of other bone cancers, and in 60% of the mesotheliomas lung cancers. Dr. Carbone believed this study could explain why 50% of the current mesotheliomas being treated were no longer occurring in association with their traditional cause of asbestos exposure.
Already sounding like a bad science fiction story, the worse news was yet to follow. An Italian team of researchers from the Institute of Histology and General Embryology of the University of Ferrara lead by Dr. Fernanda Martini discovered SV-40’s presence in various other tumors.
To be specific they found the monkey virus in 83% of choriod plexus papillomas, in 73% of ependymomas, in 47% of astrocytomas, in 50% of glioblastomas, and in 14% of meningiomas.
While the virus’s appearance in all of these types of brain tumors is mortifying, even more so is the fact that it materialized in 23% of blood samples and 45% of sperm fluids taken from normal individuals — normal meaning free of disease at the time of testing. The researchers determined the virus could be transmitted sexually and through blood transfusions.
As if to drive this point home, SV-40 has appeared in 61% of all new cancer patients — patients too young to have received the contaminated vaccine being administered forty years ago who are now believed to have been infected by human to human transmission. Being a blood born organism, it is also suspected that SV-40 is transmissible from mother to child during pregnancy.
The more this matter is researched the more startling the evidence. Senior epidemiologist at the National Institutes of Health, Dr. Howard Strickler, has plotted a geographic pattern to the cancers associated with SV-40 helping to confirm its link to the tainted vaccine. People who lived in Massachusetts and Illinois who received identified lot numbers of the contaminated vaccine administered in the 1950s are now demonstrating ten times the rate of the osteosarcoma bone tumors as those who received vaccine free of the SV-40 contaminate in other parts of the country.
The Food and Drug Administration (FDA) mandates that every American infant and child receive polio vaccinations. While public health officials continue to emphasize how current supplies of the vaccine are safe, Peter Reeve, FDA Virologist, has acknowledged that the administration abandoned independent testing of vaccine purity some fifteen years ago. The job of ensuring safety and purity rests squarely on the shoulders of those manufacturing the vaccines with no federal oversight. Wyeth-Lederle controls the supply of all the oral polio vaccine in this country, and last year’s sales totaled some $230 million dollars. Surely there would be no conflict of interest in allowing this corporation to be the sole agent of quality oversight of their own pocketbook?
The government may not have paid attention to the quality of these vaccines, but they had formulated a plan for their distribution. Federal vaccination policy advocated the use of live-virus oral polio vaccine (OPV) based on the belief the live virus shed in the body fluids of infants immunized with OPV could immunize others through contact exposure. The Centers for Disease Control (CDC) insisted this was a safe practice, and emphasized that no one previously vaccinated could contract the disease in this manner.
The public was never informed of this strategy, however, and no consent was ever obtained from the unknowing participants in this vaccination scheme. One hundred and twenty people, many previously vaccinated, contracted polio as a result of this practice. To add insult to injury in 1994 the World Health Organization proclaimed polio was eliminated from the Western Hemisphere. Insult because for the past seventeen years the only cases of polio occurring in the United States have been caused by the vaccine itself, and injury because this victory will be paid for in blood from the cancers produced by the monkey virus spread with the vaccine.
One might ask just how such a thing could happen considering the injectable form of the vaccine (IPV) does not use a live virus and doesn’t transmit the disease it is designed to shield us from? Well, Wyeth-Lederle’s leading competitor Connaught produces IVP which could explain why Wyeth lobbied so hard against the CDC recommending increased use of IVP. In 1996 the CDC revised its recommendation from four doses of OPV to two doses of IVP followed by two doses of OPV, however, physicians have been instructed to give all four doses as OPV if they desire. The cost of IVP vaccine is $5.40 per dose, whereas OPV costs $2.32 per dose. With the difference in cost favoring the use of OPV, and the current climate of regulating health care costs, clearer guidelines must come from the government if they truly expect to increase the use of the safer IVP vaccine.
Well the story of contaminated polio vaccine is not over yet.
Microbiologist Howard Urnovitz, Ph.D. provided significant evidence at the Eighth Annual Houston Conference on AIDS that human immunodeficiency virus type 1 (HIV-1) is a monkey hybrid virus which was produced when 320,000 Africans were injected with polio virus contaminated with live simian immunodeficiency virus (SIV) in the late 1950’s. Apparently, viral fragments combine easily with other viruses to produce these hybrids called “chimeras.”
This theory was confirmed by another research team headed by Dr. B. F. Elswood at the University of California in San Francisco. Interestingly enough, when researchers Cecil H. Fox and John Martin applied to the National Institutes of Health for grants to confirm the presence of SIV and simian cyto-megalovirus (SCMV) contaminates in polio vaccines their requests were denied. Dr. Urnovitz may have an explanation as he stated in the Boston Globe, “that almost 100 million Americans were exposed (to SV-40) through a government sponsored program, but for over 30 years, there has been virtually no government effort to see if anyone’s been harmed by the exposure.” He added, “The government will not fund science that makes it look culpable.”
Could it be our government, once again, is attempting to avoid a public panic while ignoring the great potential for harm these viruses could inflict. Time will tell. Harvard Medical School professor, Dr. Ronald Desroier points out that taking all known scientific evidence into account that the medical experts’ knowledge is limited to “perhaps 2% of existing monkey viruses.” Who knows what lethal virus may be discovered in our blood streams forty years from now as a result of good intentions….
Berleur, M. P., & Cordier, S. (1995). The Role of Chemical, Physical, or Viral Exposures and Health Factors in Neurocarcinogenesis: Implications for Epidemiologic Studies of Brain Tumors. Cancer Causes and Control, 6(3), 240-256.
Bookchin, D., & Schumaker, J. (1997). Tainted Polio Vaccine Still Carries Its Threat 40 Years Later. The Boston Globe, January 26.
Carbone, M., et al. (1996). SV-40 Like Sequences in Human Bone Tumors. Oncogene, 13(3), 527-535.
Elswood, B. F., & Stricker, R. B. (1995). Polio Vaccines and the Origin of AIDS. Medical Hypotheses, 42(6), 347-354.
Fisher, B. L. (1997). Workshop on Simian Virus 40: A Possible Human Polyomavirus. National Vaccine Information Center, January 27, On-line at http://www.909shot.com/polio197.htm>http://www.909shot.com/polio197.htm.
Krieg, P., Amtmann E, Jonas, D., Fischer, H., Zang, K., & Sauer G. (1981). Episomal Simian Virus 40 Genomes in Human Brain Tumors. Proceedings of the National Academy of Sciences of the United States of America, 78(10), 6446-6450.
Lednicky, J. A., Garcea, R. L., Bergsagel, D. J., & Butel, J. S. (1995). Natural Simian Virus 40 Strains are Present in Human choroid Plexus and Ependymoma tumors. Virology, 212(2), 710-717.
Martini, F., et al. (1995). Human Brain Tumors and Simian Virus 40. Journal of the National Cancer Institute, 87(17), 1331.
Martini, F., et al. (1996). SV-40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids From Healthy Individuals. Cancer Research, 56(20), 4820-4825.
Pass, H. I., Kennedy, R. C., & Carbone, M. (1996). Evidence for and Implications of SV-40 Like Sequences in Human Mesotheliomas. Important Advances in Oncology, 89-108.
Rock, A. (1996). The Lethal Dangers of the Billion Dollar Vaccine Business. Money, December, pages 148-163.
Tognon, M., et al. (1996). Large T Antigen Coding Sequences of Two DNA Tumor Viruses, BK and SV-40, and Nonrandom Chromosome Changes in Two Glioblastoma Cell Lines. Cancer Genetics and Cytogenics, 90(1), 17-23.
The Tainted History of the DPT Vaccine
In his article, “Study: Media Unintentionally Distorts Child Vaccine Risks,” David Williamson reports on some of the controversy surrounding the safety of the Diphtheria, Pertussis, and Tetanus vaccination (DPT). The debate over the safety of this vaccine cocktail has raged for decades, not just in our country but around the globe.
There’s no question that DPT vaccinations save lives; they have lowered the annual pertussis deaths from about 1000 annually to less than ten. Unfortunately, as reported by the National Vaccine Information Center (NVIC), the form of the vaccine used and sanctioned by the Centers for Disease Control also kills as many as 900 children per year, and leaves one of every 62,000 children immunized with permanent brain damage. Are those acceptable risks?
To add insult to injury, a purified vaccine is available that’s virtually reaction-free, and has been produced and used in other countries for over 15 years, using technology the U.S. abandoned in the 1970’s. The catch: it costs $9 more per injection.
While most parents would happily cough up the additional nine bucks to ensure their children’s safety, drug companies have lobbied to delay the use of the purified vaccine (acellular) for as long as possible — it might cut into their inflated 50 percent profit margins per vaccination.
Before digressing too far into the politics and economics of the public health system in this country, a brief world tour of DPT’s tainted history is in order.
By 1972, six major US pharmaceutical companies had developed a purified (acellular) form of the pertussis vaccine which was virtually reaction-free. Unfortunately, the purification process yielded less of the active component necessary to confer immunity increasing the cost of production from cents to dollars per dosage. Acellular vaccine production was abandoned. In 1977, British researcher Dr. Gordon T. Stewart, of the Department of Community Medicine at the University of Glasgow, documented adverse reactions to DPT vaccine and evaluated the benefit to risk ratio for children in the United Kingdom. His research demonstrated that 1 of every 54,000 children receiving the vaccine suffered encephalopathy (brain disfunction) with rare instances of mental retardation ensuing. Other symptoms included fits of screaming, unresponsiveness, shock, vomiting, localized paralysis, and convulsions.
Of the 160 adverse cases he examined, 40 percent demonstrated hyperkinesis (increased muscle movements accompanying brain dysfunction), infantile spasms, flaccid paralysis, and partial or complete amentia (severe mental retardation).
He determined that adverse events were severely underreported or overlooked, that no protection from the disease was demonstrable in infants, and that claims by official bodies that risks of whooping-cough exceeded those of vaccination were very questionable. He estimated the risk of transient brain damage and mental defect to occur in 1 out of every 10,000 vaccinated, and risk for permanent brain damage to occur in 1 out of every 20,000 to 60,000 vaccinated.
Sweden banned the pertussis vaccine from its vaccination program in 1979, related to concerns of safety and its questionable effectiveness. This country decided it would rather endure the disease as opposed to the vaccine. (Mr. Williamson correctly points out that the United Kingdom experienced outbreaks of pertussis during this time period, however, 100,000 cases with only 36 deaths was viewed by many as minor compared to the potential loss from mass immunizations of millions of citizens with a defective vaccine — do the math yourself — a potential for 900 deaths annually in this country alone from the vaccine.)
In 1980, German researchers, Tonz and Bajc, compared incidences of seizures caused by the pertussis vaccine in Germany with those in America. German children suffered seizures at the rate of 1 per every 4800 infants immunized while American children demonstrated a rate of 1 seizure for every 600 infants immunized.
Concerns for safety prompted Japan to replace the traditional whole-cell pertussis vaccine with the purified, acellular vaccine. By 1983, studies indicated that the efficacy of Japanese acellular vaccines was equal that of the whole-cell vaccines, and complication rates had been cut by 83 percent.
In 1984 Austrian researcher, Dr. Gerhard Wiedermann, at the Institute for Environmental Medicine at the University of Vienna, evaluated the risks versus benefits of continuing the pertussis vaccination program and concluded pertussis vaccinations should be discontinued. His research team recommended that only DT vaccinations be given, and pointed out while no deaths from the vaccine had been confirmed in their country that, “pertussis offers many ailments, sufferings, and possibilities of damage.”
That same year, Dr. Alan Hinman of the Division of Immunization at the Center for Prevention Services, along with Dr. Jeffrey Koplan of the Centers for Disease Control, produced a simulated model of 1 million children to examine the risks versus benefits of pertussis vaccine in the United States. These researchers concluded the over-all benefits outweighed the risks — but they also documented the extent of damage this vaccine can cause. One minor reaction was predicted to occur with every 2.5 doses, one case of convulsions with every 1,750 doses, one child would collapse (shock) with every 1,750 doses, one case of encephalitis would occur with every 110,000 doses with a case of permanent brain damage with every 310,000 doses. Magnify these risks five times as each child receives 5 doses to complete the immunization schedule.
In 1992, Doctors Paul Fine and Robert Chen of the Communicable Disease Epidemiological Unit in London performed a re-analysis of studies on DPT which revealed previously under-reported complications. Their analysis of the British National Childhood Encephalopathy Study lead to a four-fold increase in the estimated risk of encephalopathy associated with DPT vaccinations. The investigators added that “(research) biases that underestimate risk have received less attention (than those over-estimating risks),” and “the fact that such biases do exist makes it difficult to demonstrate convincingly that a vaccine is not responsible for rare, severe, adverse reactions.”
Dr. Kathleen Stratton and her colleagues at the Institute of Medicine reported in 1994 the Diphtheria and Tetanus (DT) portions of the DPT cocktail had been causally related to anaphylactic reactions (severe allergic reactions), Guillain-Barre Syndrome (numbness of the extremities with severe forms producing various degrees of paralysis), and brachial neuritis (inflammation of the brachial nerve). It remains inconclusive as to whether or not these portions of the vaccine cause residual seizure disorders, demyelinating diseases of the central nervous system (infections of nerve cell linings causing muscle weakness and visual disturbances), mononeuropathy (single nerve inflammation), and arthritis. As of last year, the Institute reported that no controlled clinical trials had been conducted to rule out a causal link between DPT and encephalopathy, demyelinating diseases, Guillain-Barre syndrome, and anaphylaxis!
When the major vaccine manufacturers lobbied Congress in 1986 to pass the National Childhood Vaccine Injury Act (NCVIA) to absolve them of all liability related to adverse reactions caused by their products, they obviously had plenty to worry about. With this Act, the National Vaccine Injury Fund was established by levying a user tax against citizens for immunizing their children. Since its creation the fund has compensated 579 vaccine induced deaths adjudicated through the Federal Court of Claims to the tune of $700 million dollars. Forty percent (227) of these vaccine induced deaths were originally misdiagnosed as Sudden Infant Death Syndrome (SIDS). Mind you, the American taxpayer now compensates the victims of these defective products, while the major manufacturer and supplier of DPT in the U.S., Wyeth-Lederle, watched its profits soar 300 percent since the passage of this Act. Wyeth-Lederle earned $350 million in sales of DPT last year.
Mr. Williamson’s figures on the malpractice damage suits are somewhat misleading as well. There is a great difference between filing a malpractice case and having damages awarded to the victims of medical malpractice. All told, the dollar amount associated with litigation for negligent practice totals up to only one percent, or $10 billion dollars, of the total annual healthcare tab. (This is for all malpractice litigation, and vaccine litigation is but a small portion of this amount.)
The Congressional Budget Office (CBO) confirms these figures which include all malpractice settlements, all malpractice insurance premiums, all legal fees, and all court costs. Furthermore, the Harvard Medical Practice Study revealed that of the one percent of patients estimated to be injured as a result of negligence only one-eighth ever discovered they were victimized and filed suit, and only one-sixteenth of those filing suits ever recovered any monetary damages. The damage awards themselves have been on a steady decline over the past ten years, and out of court settlements plummeted from an average of $2 million in 1993 to $1 million in 1994. Jury awards have decreased even further to an average of $500,000 per case.
It is probably correct that some 250 lawsuits were being brought against the manufacturers of vaccines by 1986 prior to the legislative relief granted to these companies. Problem is, there most probably should have been more — many more.
Most people don’t realize when they have been victimized by negligent practice or by defective products. Very few file suit, and when the cause of many of these deaths and disabilities are misdiagnosed it becomes very easy for this industry to write off its adverse reactions by saying they just happen to be a coincidence of normal childhood neurological disorders.
As pointed out earlier, 40 percent of the victims compensated after passage of the NCVIA had been misdiagnosed originally. This figure is consistent with many studies by pathologists documenting rates of misdiagnosis at 35 to 40 percent as to the cause of death in all range of ailments. An increase in autopsies appears to be indicated if one is to discount or subscribe to the coincidence theory.
While some argue the damage caused by these vaccines is rare, and over just how many have suffered these negative side-effects, it is clear that many adverse reactions go unreported, over-looked, or misdiagnosed.
(In one 20 month period alone, the National Vaccine Information Center documented 54,000 adverse vaccine reactions which included 700 deaths. Dr. David Kessler, now retiring commissioner of the FDA added that only 1 of every 10 adverse events associated with vaccines are reported.)
I personally can’t image too many crimes worse than destroying the life of a child with a product which is known to have negative side effects when there is a safer product available but simply not being pursued because there is not enough profit motive in it for the manufacturer — this is public health, not toasters which are being sold!
In 1996, the CDC approved using the acellular (purified form) of the DPT vaccine for use in 15 month-old children in the U.S., and it is now being evaluated in controlled trials. It is interesting to note that up until 1995, five of the nine representatives of the Centers for Disease Control Immunization Advisory Panel had financial ties to the industry. The Chairman, Dr. James Cherry, acknowledged the risks of severe brain damage and death from the DPT vaccinations in 1979, but by 1990 he had done an about face and declared these known dangers as being “myths.” Between the years 1980 through 1992, Dr. Cherry had received over a million dollars in unrestricted DPT research grants from Lederle — DPT’s largest manufacturer.
Some twenty-four years after the development of the purified vaccine, with the U.S. pursuing it once again, all that remains are the questions of the discarded victims and the fears of parents who must chose whether or not to immunize their children.
Aoyama, T., Murase, Y., Kato, T. & Iwata, T. (1985). Efficacy of an Acellular Pertussis Vaccine in Japan. Journal of Pediatrics, 107(2), 180- 183.
Fine, P. E. & Chen, R. T. (1992). Confounding in Studies of Adverse Reactions to Vaccines. American Journal of Epidemiology, 136(2), 121-135.
Hallander, G. L. , Olin. P., & Storsaeter, R. E. (1996). A Controlled Trial of a Two-component Acellular, a Five-Component Acellular, and a Whole-Cell pertussis Vaccine. New England Journal of Medicine, 334(6), 391-392.
Hinman, A. R. & Koplan, J. P. (1984). Pertussis and Pertussis Vaccine. Journal of the American Medical Association, 251(23), 3109- 3113.
Rock, A. (1996). The Lethal Dangers of the Billion Dollar Vaccine Business. Money, December, pps. 148-164.
Stewart, G. T. (1977). Vaccination Against Whooping-Cough: Efficacy Versus Risks. The Lancet, 8005, 234-237, January 29.
Stratton, K.. , Howe, C. J., & Johnston, R. B. (1994). Adverse Events Associated with Childhood Vaccines Other Than Pertussis and Rubella. Journal of the American Medical Association, 271(20), 1602-1605.
Tonz, O. & Bajc, S. (1980). Zerebrale Krampfanfalle Nach Pertussis-Impfung. Schweizerische Medizinische Wochenschrift, 110(51) 1965-71. (English translation included)
Wiedermann, G., Ambrosch, F., Kollaritsch, H. & Kundi, M. (1984). Risks and Benefits of Vaccinations. Infection Control, 5(9), 438-444.
My bio for the Albion Monitor:
Harold Stearley, R.N., B.S.N., A.S.B., CCRN, has held various clinical and supervisory positions over his two-decade career. His articles on “managed care” and the crisis in nursing have appeared in many nursing journals, and he was the author of “Nursing on the Edge,” a multi-part series which appeared in the Monitor last year.